The drug company Pfizer announced test results Monday showing its COVID-19 vaccine prevents 90% of infections in volunteers who had not previously contracted the coronavirus.
The company says in a press release it will request permission from the Food and Drug Administration to make the vaccine available under an “emergency use authorization” by the third week of November.
Pfizer projects it will be able to produce up to 50 million vaccine doses in 2020 and 1.3 billion doses in 2021.
Michigan Capitol Confidential is the news source produced by the Mackinac Center for Public Policy. Michigan Capitol Confidential reports with a free-market news perspective.